Cryopreserved vs. Lyopreserved Stravix as an Adjunct to NPWT in the Treatment of Complex Wounds
Completed · Phase 4
Conditions studied: Diabetic Wound
In brief
This study is a prospective, 2-arm parallel assignment, randomized clinical trial to compare lyopreserved vs cryopreserved Stravix as an adjunct therapy to NPWT.
Key facts
- Study ID
- NCT04405765
- Run by
- University of Texas Southwestern Medical Center
- People needed
- 46
- Starts
- 2021-06-22
- Expected to finish
- 2022-07-07
- Last updated by the study team
- 2023-07-24
Who can join
Age: 21 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosis of a diabetes mellitus
- Men/women ≥21 years old
- Post-operative foot or ankle wounds sized >4cm2 that have presented for <1 year
- ABI ≥0.5 or toe pressures >30 mmHg
- Wounds indicated for treatment with NPWT
You may not qualify if…
- Active Charcot arthropy
- Unable to use NPWT at home
- Untreated bone or soft tissue infection
- Is pregnant or plans to become pregnant
- Is nursing or actively lactating
- Developmental disability/significant psychological disorder that in the opinion of the investigator could impair the subject's ability to provide informed consent, participate in the study protocol or record study measures, including untreated schizophrenia, bipolar disorder and psychiatric hospitalization within the last 2 years.
- Active alcohol or substance abuse in the opinion of the investigator that could impair the subject's ability to provide informed consent, participate in the study protocol or record study materials
Where it is running
- UT Southwestern Medical Center at Dallas — Dallas, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.